Error: Could not add to watchlist. X

Eventide Healthcare & Life Sciences Fund

+ Watchlist
ETAHX:US
NASDAQ GM
25.72
USD
0.11
0.43%
As of 09:29:30 ET on 07/02/2015.
Volume
0
Previous Close
25.83
52Wk Range
15.19 - 26.80
1 Yr Return
43.77%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/02/2015)
25.72
Total Assets (m USD) (on 07/02/2015)
298.873
Inception Date
12/27/2012
Last Dividend (on 12/31/2014)
-
Dividend Indicated Gross Yield
-
Fund Managers
FINNY GEORGE KURUVILLA
Front Load Fee
5.75%
Back Load Fee
0.00%
Redemption Fee
1.00%
12b-1 Fee
0.25%
Current Mgmt Fee
1.10%
Expense Ratio
1.68%
Top Fund Holdings
Name Position Value % of Fund
Fidelity Institutional Money M 34.71 m 34.71 m 16.26
Bluebird Bio Inc 74.00 k 8.94 m 4.19
Neurocrine Biosciences Inc 137.80 k 5.47 m 2.56
Cempra Inc 153.80 k 5.28 m 2.47
Veracyte Inc 705.80 k 5.14 m 2.41
Tetraphase Pharmaceuticals Inc 139.00 k 5.09 m 2.38
Dyax Corp 303.00 k 5.08 m 2.38
TESARO Inc 87.70 k 5.03 m 2.36
Five Prime Therapeutics Inc 219.30 k 5.01 m 2.35
BioMarin Pharmaceutical Inc 40.10 k 5.00 m 2.34
Profile
Eventide Healthcare & Life Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund will invest at least 80% of its net assets in equity and equity-related securities of companies in the healthcare and life sciences industries.
ADDRESS
Catalyst Funds
630-A Fitzwatertown Road
2nd Floor
Willow Grove, PA 19090-1904
PHONE
1-866-447-4228